Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD51 | Q06609 | 5/20 | 0.80 |
| ▸ | RAD1 | O60671 | 1/20 | 0.70 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.70 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.66 |
| ▸ | APEX1 | P27695 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | USP2 | O75604 | 2/20 | 0.53 |
| ▸ | LTA | P01374 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | SENP3 | Q9H4L4 | 4/20 | 0.42 |
| ▸ | SENP2 | Q9HC62 | 4/20 | 0.42 |
| ▸ | SENP1 | Q9P0U3 | 4/20 | 0.42 |
| ▸ | SUMO2 | P61956 | 3/20 | 0.42 |
| ▸ | SUMO1 | P63165 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15823509 | 1.00 | RAD51 (0.80) | RAD51RAD1P2RY6ENPP2APEX1 | |
| SCHEMBL175934 | 0.99 | RAD51 (0.81) | RAD51RAD1P2RY6ENPP2APEX1 | |
| SCHEMBL29351606 | 0.99 | RAD51 (0.81) | RAD51RAD1P2RY6ENPP2APEX1 | |
| SCHEMBL25796 | 0.99 | RAD51 (0.81) | RAD51RAD1P2RY6ENPP2APEX1 | |
| SCHEMBL2333711 | 0.98 | RAD51 (0.80) | RAD51RAD1P2RY6ENPP2APEX1 | |
| SCHEMBL30160852 | 0.98 | RAD51 (0.80) | RAD51RAD1P2RY6ENPP2APEX1 | |
| SCHEMBL5616054 | 0.91 | RAD51 (0.70) | RAD51RAD1P2RY6ENPP2APEX1 | |
| Acridine SCHEMBL6290391 | 0.89 | RAD51 (0.67) | RAD51RAD1P2RY6ENPP2APEX1 | |
| Acridine SCHEMBL722533 | 0.89 | RAD51 (0.67) | RAD51RAD1P2RY6ENPP2APEX1 | |
| SCHEMBL4857676 | 0.88 | ENPP2 (0.69) | RAD51RAD1P2RY6ENPP2APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | ACENET INC. (JP) | 2024-01-04 | — | — | US | disclosed |
| US-20230263710-A1 | ORAL CARE AGENT | OSAKA UNIVERSITY (JP) | 2023-08-24 | — | — | US | disclosed |
| EP-4230042-A1 | ANTIPATHOGENIC DRUG, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN PROCESSING DEVICE, METHOD FOR PRODUCING ANTIPATHOGENIC DRUG, ANTIBACTERIAL METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN PROCESSING METHOD | Acenet Inc. (JP) | 2023-08-23 | — | — | EP | disclosed |
| US-20230181628-A1 | EPITHELIAL CANCER THERAPEUTIC AGENT | OSAKA UNIVERSITY (JP) | 2023-06-15 | — | — | US | disclosed |
| EP-4147703-A1 | EPITHELIAL CANCER THERAPEUTIC AGENT | OSAKA UNIVERSITY (JP) | 2023-03-15 | — | — | EP | disclosed |
| US-20200171118-A1 | RADICAL GENERATING CATALYST, METHOD FOR PRODUCING RADICAL, METHOD FOR PRODUCING OXIDATION REACTION PRODUCT, DRUG, AND DRUG FOR USE IN AGRICULTURE AND LIVESTOCK INDUSTRY | ACENET INC. (JP) | 2020-06-04 | — | — | US | disclosed |
| EP-3626339-A1 | RADICAL-GENERATING CATALYST, RADICAL PRODUCTION METHOD, OXIDATION REACTION PRODUCT PRODUCTION METHOD, CHEMICAL AGENT, AND CHEMICAL AGENT FOR AGRICULTURE AND LIVESTOCK | Acenet Inc. (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-20130189280-A1 | PROTEIN DOMAINS AND USES THEREFOR | SYDNEY WEST AREA HEALTH SERVICE (SWAHS) (AU) | 2013-07-25 | — | — | US | disclosed |
| EP-2533794-A1 | PROTEIN DOMAINS AND USES THEREFOR | The University Of Sydney (AU) | 2012-12-19 | — | — | EP | disclosed |
| WO-2011097688-A1 | PROTEIN DOMAINS AND USES THEREFOR | THE UNIVERSITY OF SYDNEY (AU) | 2011-08-18 | — | — | WO | disclosed |
| US-5512667-A | Trifunctional intermediates for preparing 3'-tailed oligonucleotides | DRUG ROYALTY LP1 (CA) | 1996-04-30 | — | — | US | disclosed |
| US-5419966-A | Solid support for synthesis of 3'-tailed oligonucleotides | MICROPROBE CORPORATION (US) | 1995-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263710-A1 | ORAL CARE AGENT | TAS2R39, TAS2R40, TAS2R45 | RAD51 2257/4885RAD1 3191/4885P2RY6 3452/4885 |
| US-20200171118-A1 | RADICAL GENERATING CATALYST, METHOD FOR PRODUCING RADICAL, METHOD FOR PRODUCING OXIDATION REACTION PRODUCT, DRUG, AND DRUG FOR USE IN AGRICULTURE AND LIVESTOCK INDUSTRY | PRDX2, PRDX1, PRDX5 | RAD51 1869/4885RAD1 3102/4885P2RY6 1080/4885 |
| US-20230181628-A1 | EPITHELIAL CANCER THERAPEUTIC AGENT | EPCAM, EGFR, MUC1 | RAD51 669/4885RAD1 1888/4885P2RY6 4514/4885 |
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | EIF2AK2, HAO2, ZC3HAV1 | RAD51 1411/4885RAD1 298/4885P2RY6 1998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.